A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry

Bente Glintborg; Inge Juul Sørensen; Dorte Vendelbo Jensen; Niels Steen Krogh; A. G.  Loft; J. Espesen; J. Olsen; O. Hendricks; J. Grydehøj; I. M. J. Hansen; M. V. Sørensen; S. Chrysidis; B. L. Andersen; N. Manilo; Mette Klarlund; L. S. Andersen; Henrik  Nordin; S. Kristensen; Jesper Nørregaard; Merete Lund Hetland

A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry

Bente Glintborg, Inge Juul Sørensen, Dorte Vendelbo Jensen, Niels Steen Krogh, A. G. Loft, J. Espesen, J. Olsen, O. Hendricks, J. Grydehøj, I. M. J. Hansen, M. V. Sørensen, S. Chrysidis, B. L. Andersen, N. Manilo, Mette Klarlund, L. S. Andersen, Henrik Nordin, S. Kristensen, Jesper Nørregaard, Merete Lund Hetland

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	951
Tidsskrift	Arthritis & Rheumatology
Vol/bind	68
Udgave nummer	S10
ISSN	1537-2960
Status	Udgivet - 2016

Citationsformater

Glintborg, B., Sørensen, I. J., Jensen, D. V., Krogh, N. S., Loft, A. G., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I. M. J., Sørensen, M. V., Chrysidis, S., Andersen, B. L., Manilo, N., Klarlund, M., Andersen, L. S., Nordin, H., Kristensen, S., Nørregaard, J., & Hetland, M. L. (2016). A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry. Arthritis & Rheumatology, 68(S10), [951].

A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry. / Glintborg, Bente ; Sørensen, Inge Juul ; Jensen, Dorte Vendelbo et al.

I: Arthritis & Rheumatology, Bind 68, Nr. S10, 951, 2016.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Glintborg, B , Sørensen, IJ , Jensen, DV, Krogh, NS, Loft, AG, Espesen, J, Olsen, J, Hendricks, O, Grydehøj, J, Hansen, IMJ, Sørensen, MV, Chrysidis, S, Andersen, BL, Manilo, N, Klarlund, M, Andersen, LS, Nordin, H, Kristensen, S, Nørregaard, J & Hetland, ML 2016, 'A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry', Arthritis & Rheumatology, bind 68, nr. S10, 951.

@article{2f999c1e879b4c01b19b727a6a174e4a,

title = "A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months{\textquoteright} Clinical Outcomes from the Danbio Registry",

author = "Bente Glintborg and S{\o}rensen, {Inge Juul} and Jensen, {Dorte Vendelbo} and Krogh, {Niels Steen} and Loft, {A. G.} and J. Espesen and J. Olsen and O. Hendricks and J. Grydeh{\o}j and Hansen, {I. M. J.} and S{\o}rensen, {M. V.} and S. Chrysidis and Andersen, {B. L.} and N. Manilo and Mette Klarlund and Andersen, {L. S.} and Henrik Nordin and S. Kristensen and Jesper N{\o}rregaard and Hetland, {Merete Lund}",

year = "2016",

language = "English",

volume = "68",

journal = "Arthritis & Rheumatology",

issn = "1537-2960",

publisher = "eMedguides.com",

number = "S10",

}

TY - ABST

T1 - A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Krogh, Niels Steen

AU - Loft, A. G.

AU - Espesen, J.

AU - Olsen, J.

AU - Hendricks, O.

AU - Grydehøj, J.

AU - Hansen, I. M. J.

AU - Sørensen, M. V.

AU - Chrysidis, S.

AU - Andersen, B. L.

AU - Manilo, N.

AU - Klarlund, Mette

AU - Andersen, L. S.

AU - Nordin, Henrik

AU - Kristensen, S.

AU - Nørregaard, Jesper

AU - Hetland, Merete Lund

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

VL - 68

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 1537-2960

IS - S10

M1 - 951

ER -